Upregulation of M3 muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II

被引:22
作者
Liu, Yan [1 ]
Wang, Shu [1 ,2 ]
Wang, Chao [1 ]
Song, Haoxin [1 ]
Han, Hongmei [1 ]
Hang, Pengzhou [1 ,3 ]
Jiang, Yanan [1 ]
Wei, Lanlan [4 ]
Huo, Rong [1 ]
Sun, Lihua [1 ]
Gao, Xu [5 ]
Lu, Yanjie [1 ]
Du, Zhimin [1 ,3 ]
机构
[1] Harbin Med Univ, Dept Pharmacol, State Prov Key Lab China, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiac Care Unit, Harbin 150081, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Hosp 2, Inst Clin Pharmacol, Harbin 150081, Heilongjiang, Peoples R China
[4] Dept Microbiol, Harbin 150081, Heilongjiang, Peoples R China
[5] Harbin Med Univ, Dept Biochem, Harbin, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Cardiac hypertrophy; M-3 muscarinic acetylcholine receptor; Angiotensin II; Choline; ACETYLCHOLINE-RECEPTORS; DILATED CARDIOMYOPATHY; HEART-RATE; ACTIVATION; SUBTYPES; MICE;
D O I
10.1186/1479-5876-11-209
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: M-3 muscarinic acetylcholine receptor (M-3-mAChR) is stably expressed in the myocardium, but its pathophysiological role remains largely undefined. This study aimed to investigate the role of M-3-mAChR in cardiac hypertrophy induced by angiotensin II (Ang II) and elucidate the underlying mechanisms. Methods: Cardiac-specific M-3-mAChR overexpression transgenic (TG) mice and rat H9c2 cardiomyoblasts with ectopic expression of M-3-mAChR were established. Models of cardiac hypertrophy were induced by transverse aortic constriction (TAC) or Ang II infusion in the mice in vivo, and by isoproterenol (ISO) or Ang II treatment of H9c2 cells in vitro. Cardiac hypertrophy was evaluated by electrocardiography (ECG) measurement, hemodynamic measurement and histological analysis. mRNA and protein expression were detected by real-time RT-PCR and Western blot analysis. Results: M-3-mAChR was upregulated in hypertrophic heart, while M-2-mAChR expression did not change significantly. M-3-mAChR overexpression significantly attenuated the increased expression of atrial natriuretic peptide and beta-myosin heavy chain induced by Ang II both in vivo and in vitro. In addition, M-3-mAChR overexpression downregulated AT(1) receptor expression and inhibited the activation of MAPK signaling in the heart. Conclusion: The upregulation of M-3-mAChR during myocardial hypertrophy could relieve the hypertrophic response provoked by Ang II, and the mechanism may involve the inhibition of MAPK signaling through the downregulation of AT(1) receptor.
引用
收藏
页数:8
相关论文
共 30 条
[1]   Effects of p38 MAPK inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production [J].
Bao, Weike ;
Behm, David J. ;
Nerurkar, Sandhya S. ;
Ao, Zhaohui ;
Bentley, Ross ;
Mirabile, Rosanna C. ;
Johns, Douglas G. ;
Woods, Tina N. ;
Doe, Christopher P. A. ;
Coatney, Robert W. ;
Ohlstein, Jason F. ;
Douglas, Stephen A. ;
Willette, Robert N. ;
Yue, Tian-Li .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (06) :362-368
[2]   Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials [J].
Cucherat, Michel .
EUROPEAN HEART JOURNAL, 2007, 28 (24) :3012-3019
[3]   Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial [J].
Fox, Kim ;
Ford, Ian ;
Steg, P. Gabriel ;
Tendera, Michal ;
Robertson, Michele ;
Ferrari, Roberto .
LANCET, 2008, 372 (9641) :817-821
[4]   Calsarcin-1 protects against angiotensin-II-induced cardiac hypertrophy [J].
Frank, Derk ;
Kuhn, Christian ;
van Eickels, Martin ;
Gehring, Doris ;
Hanselmann, Christiane ;
Lippl, Stefanie ;
Will, Rainer ;
Katus, Hugo A. ;
Frey, Norbert .
CIRCULATION, 2007, 116 (22) :2587-2596
[5]   Hypertrophy of the heart - A new therapeutic target? [J].
Frey, N ;
Katus, HA ;
Olson, EN ;
Hill, JA .
CIRCULATION, 2004, 109 (13) :1580-1589
[6]   Sympathetic α2-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload [J].
Gilsbach, Ralf ;
Schneider, Johanna ;
Lother, Achim ;
Schickinger, Stefanie ;
Leemhuis, Jost ;
Hein, Lutz .
CARDIOVASCULAR RESEARCH, 2010, 86 (03) :432-442
[7]   Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload [J].
Grote-Wessels, Stephanie ;
Baba, Hideo A. ;
Boknik, Peter ;
El-Armouche, Ali ;
Fabritz, Larissa ;
Gillmann, Hans-Jorg ;
Kucerova, Dana ;
Matus, Marek ;
Muller, Frank U. ;
Neumann, Joachim ;
Schmitz, Martina ;
Stumpel, Frank ;
Theilmeier, Gregor ;
Wohlschlaeger, Jeremias ;
Schmitz, Wilhelm ;
Kirchhefer, Uwe .
CARDIOVASCULAR RESEARCH, 2008, 79 (03) :464-471
[8]   Regulation of cardiac hypertrophy by intracellular signalling pathways [J].
Heineke, Joerg ;
Molkentin, Jeffery D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (08) :589-600
[9]   Increased myocardial NADPH oxidase activity in human heart failure [J].
Heymes, C ;
Bendall, JK ;
Ratajczak, P ;
Cave, AC ;
Samuel, JL ;
Hasenfuss, G ;
Shah, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2164-2171
[10]   Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol [J].
Kasama, Shu ;
Toyama, Takuji ;
Hatori, Takashi ;
Sumino, Hiroyuki ;
Kumakura, Hisao ;
Takayama, Yoshiaki ;
Ichikawa, Shuichi ;
Suzuki, Tadashi ;
Kurabayashi, Masahiko .
EUROPEAN HEART JOURNAL, 2007, 28 (08) :989-995